EyeD Pharma was created in 2012 on the initiative of Professor Jean-Marie Rakic (Head of the Ophthalmology Department at Liège University Hospital, CHU), together with a group of other ophthalmologists and a few private investors.
Currently, the company is developing an innovative drug delivery system based on a controlled-release intraocular implant.
EyeD Pharma is initially focusing on the treatment of glaucoma, an eye disease that mainly affects people over the age of 45. Traditionally, glaucoma is treated by administering eye drops every day for the rest of the patient’s life. This drug treatment is very burdensome and causes local side effects, such as eye irritation. If the patient is not treated or is inconsistent in taking the treatment, glaucoma is accompanied by irreversible degeneration of the optic nerve, resulting in loss of vision (second biggest cause of blindness in developed countries).
Website
Location: Belgium, Liège
Employees: 11-50
Total raised: $50.95M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | Fund+ | fundplus.b... |
| - | SFPIM | sfpim.be |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.12.2021 | - | $50.95M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 24.12.2021 | Belgium-based EyeD Pharma raises €45M to develop innovative ... | Liege-based EyeD Pharma, a pharmaceutical company dedicated to the development of innovative drug pr... | siliconcan... |
| 23.12.2021 | EyeD Pharma raises ⬠32M funding round | Liege, 22 December 2021 - The Liège-based pharmaceutical company, EyeD Pharma, received the backing... | qbic.be/ni... |
| 23.05.2019 | Belgian biotech startup EyeD develops eye implant to prevent... | Eye healthcare is seeking more attention than ever! Numerous health tech startups are popping up wit... | siliconcan... |